In a previous report, we demonstrated that, in lung cancer, RARα is responsible for mediating the nongenomic effects of ATRA by forming a signaling complex that is able to activate PI3K within the first few minutes after treatment with ATRA. Here, RARA is linked to lung carcinoma.